Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, December 20, 2014
 
Register | Sign in
Home Page>Products
  Product News
Merck Millipore Launches Kit for Analyzing NF?B Translocation
Thursday, November 20, 2014
Permits quantitative, statistically robust assessment of NF?B translocation.

Optimizing Workflow with 96- & 384-well Microplates
Thursday, November 20, 2014
INTEGRA has introduced a Three Position Stage for its VIAFLO 96 and VIAFLO 384 handheld benchtop pipettes.

Bio-Rad Launches Benchtop S3e™ Cell Sorter with AutoGimbal™ Nozzle Alignment System
Thursday, November 20, 2014
Walk-away automation for accurate and reliable cell sorts of one or two populations.

New ambr® 15 Webinar on Overcoming Bottlenecks in Cell Line Development
Wednesday, November 19, 2014
Features data showing how this technology can improve biologics manufacturing.

Affordable, Reliable Quality Imaging with the SC50 Camera
Wednesday, November 19, 2014
High quality digital microscopy is now more accessible than ever with the new 5 Megapixel SC50 microscope camera from Olympus, bringing fast, Full HD live imaging and more to a host of routine applications.

Irvine Scientific Introduces DMSO-Free
Wednesday, November 19, 2014
A chemically-defined cryopreservation solution for mesenchymal stem cells.

Porvair Launches Electronic Mat Capper
Wednesday, November 19, 2014
E-capper minimises the risk of RSI in operators.

Specialist Catalogue for Electrophoresis Equipment & Supplies
Tuesday, November 18, 2014
New 2015 catalogue includes many exciting new products including COMPAC-50 high throughput COMET Assay system.

Asynt PressureSyn Wins Innovation Award
Tuesday, November 18, 2014
A high pressure reactor designed to work on any magnetic hotplate stirrer.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 10725
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn